| Dr Nancy Bello, DO | |
|
2851 S Avenue B Bldg 20, Yuma, AZ 85364-7726 | |
| (928) 344-2434 | |
| (928) 344-2435 |
| Full Name | Dr Nancy Bello |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 12 Years |
| Location | 2851 S Avenue B Bldg 20, Yuma, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669734620 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | R2127 (Arizona) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | 007337 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yuma Regional Medical Center | Yuma, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yuma Regional Medical Center | 2062314826 | 288 |
News Archive
Small pieces of nucleic acid known as short interfering RNAs, or siRNAs, can turn off the production of specific proteins, a property that makes them one of the more promising new classes of anticancer drugs in development. Indeed, at least two siRNA-based anticancer therapies, both delivered to tumors in nanoparticles, have begun human clinical trials.
A Cochrane review of the accuracy of skin cancer diagnostics has found that visual inspection of suspicious lesions is insufficient to ensure an accurate diagnosis.
A new free, white paper that guides medical device manufacturers in the complicated process of applying new U.S. Food and Drug Administration (FDA) regulations to combination products embedded with pharmaceutical or biologic components is now available from Microtest Laboratories (http://www.microtestlabs.com/combination-products-20/)
A new study published in the Journal of Investigative Dermatology reports that half the skin lesions present in patients with lupus show the presence of viable staph bacteria. This makes them more susceptible to skin infections and also increases the risk that the infection will spread to others.
› Verified 9 days ago
| Entity Name | Yuma Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194706655 PECOS PAC ID: 2062314826 Enrollment ID: O20040122000526 |
News Archive
Small pieces of nucleic acid known as short interfering RNAs, or siRNAs, can turn off the production of specific proteins, a property that makes them one of the more promising new classes of anticancer drugs in development. Indeed, at least two siRNA-based anticancer therapies, both delivered to tumors in nanoparticles, have begun human clinical trials.
A Cochrane review of the accuracy of skin cancer diagnostics has found that visual inspection of suspicious lesions is insufficient to ensure an accurate diagnosis.
A new free, white paper that guides medical device manufacturers in the complicated process of applying new U.S. Food and Drug Administration (FDA) regulations to combination products embedded with pharmaceutical or biologic components is now available from Microtest Laboratories (http://www.microtestlabs.com/combination-products-20/)
A new study published in the Journal of Investigative Dermatology reports that half the skin lesions present in patients with lupus show the presence of viable staph bacteria. This makes them more susceptible to skin infections and also increases the risk that the infection will spread to others.
› Verified 9 days ago
| Entity Name | Summit Healthcare Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144209271 PECOS PAC ID: 3779568647 Enrollment ID: O20040623001125 |
News Archive
Small pieces of nucleic acid known as short interfering RNAs, or siRNAs, can turn off the production of specific proteins, a property that makes them one of the more promising new classes of anticancer drugs in development. Indeed, at least two siRNA-based anticancer therapies, both delivered to tumors in nanoparticles, have begun human clinical trials.
A Cochrane review of the accuracy of skin cancer diagnostics has found that visual inspection of suspicious lesions is insufficient to ensure an accurate diagnosis.
A new free, white paper that guides medical device manufacturers in the complicated process of applying new U.S. Food and Drug Administration (FDA) regulations to combination products embedded with pharmaceutical or biologic components is now available from Microtest Laboratories (http://www.microtestlabs.com/combination-products-20/)
A new study published in the Journal of Investigative Dermatology reports that half the skin lesions present in patients with lupus show the presence of viable staph bacteria. This makes them more susceptible to skin infections and also increases the risk that the infection will spread to others.
› Verified 9 days ago
| Entity Name | Virtual Neurology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760940167 PECOS PAC ID: 9830425321 Enrollment ID: O20200212000883 |
News Archive
Small pieces of nucleic acid known as short interfering RNAs, or siRNAs, can turn off the production of specific proteins, a property that makes them one of the more promising new classes of anticancer drugs in development. Indeed, at least two siRNA-based anticancer therapies, both delivered to tumors in nanoparticles, have begun human clinical trials.
A Cochrane review of the accuracy of skin cancer diagnostics has found that visual inspection of suspicious lesions is insufficient to ensure an accurate diagnosis.
A new free, white paper that guides medical device manufacturers in the complicated process of applying new U.S. Food and Drug Administration (FDA) regulations to combination products embedded with pharmaceutical or biologic components is now available from Microtest Laboratories (http://www.microtestlabs.com/combination-products-20/)
A new study published in the Journal of Investigative Dermatology reports that half the skin lesions present in patients with lupus show the presence of viable staph bacteria. This makes them more susceptible to skin infections and also increases the risk that the infection will spread to others.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nancy Bello, DO 2851 S Avenue B Bldg 20, Yuma, AZ 85364-7726 Ph: (928) 336-2434 | Dr Nancy Bello, DO 2851 S Avenue B Bldg 20, Yuma, AZ 85364-7726 Ph: (928) 344-2434 |
News Archive
Small pieces of nucleic acid known as short interfering RNAs, or siRNAs, can turn off the production of specific proteins, a property that makes them one of the more promising new classes of anticancer drugs in development. Indeed, at least two siRNA-based anticancer therapies, both delivered to tumors in nanoparticles, have begun human clinical trials.
A Cochrane review of the accuracy of skin cancer diagnostics has found that visual inspection of suspicious lesions is insufficient to ensure an accurate diagnosis.
A new free, white paper that guides medical device manufacturers in the complicated process of applying new U.S. Food and Drug Administration (FDA) regulations to combination products embedded with pharmaceutical or biologic components is now available from Microtest Laboratories (http://www.microtestlabs.com/combination-products-20/)
A new study published in the Journal of Investigative Dermatology reports that half the skin lesions present in patients with lupus show the presence of viable staph bacteria. This makes them more susceptible to skin infections and also increases the risk that the infection will spread to others.
› Verified 9 days ago
Dr. Romila Mushtaq, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2400 S Avenue A, Yuma, AZ 85364 Phone: 928-726-6335 Fax: 928-726-6338 | |
Linda A Marden, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2400 S Avenue A, Yuma, AZ 85364 Phone: 928-344-2000 Fax: 928-336-7520 | |
Mitali Sathi Mitra, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3818 W 16th St Bldg 5, Yuma, AZ 85364 Phone: 928-317-0177 | |
Julio Zonis, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1025 W 24th St, Ste. 30, Yuma, AZ 85364 Phone: 928-344-8485 Fax: 928-344-9031 | |
Brooke Parish, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2400 S Avenue A, Yuma, AZ 85364 Phone: 928-336-2000 Fax: 505-272-8692 | |
Mrs. Marieclaire Mbah Acha, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 11468 N Frontage Rd Ste A, Yuma, AZ 85367 Phone: 928-342-6500 | |
Bapu Chand Aluri, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1230 W 24th St, Ste 1, Yuma, AZ 85364 Phone: 928-314-3702 Fax: 928-314-4687 |